Science Will Win
19 episodes - English - Latest episode: 2 days ago - ★★★★ - 76 ratingsScience Will Win is a podcast that takes listeners under the microscope of some of the most promising medical innovations, exploring therapies that have the potential to shape the future of healthcare and offer new hope to patients around the world. Through conversations with a diverse line-up of guests, including scientists and experts, patient advocates, and, most importantly, patients themselves, each miniseries will focus on a unique healthcare challenge, diving into the fascinating science, policy challenges, and potential to transform patients’ lives for the better.
This podcast is powered by Pfizer.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Live from SXSW - Moonshot Culture: Innovating to Outdo Yesterday
April 18, 2024 10:00 - 49 minutes - 45.3 MBThroughout history, humans have coalesced around moonshot culture to achieve audacious goals—from eradicating smallpox, to sequencing the human genome, to landing a spacecraft on Mars. These feats of human ingenuity didn’t happen in a vacuum, they were born from intentional innovation, a “coalition of the willing,” and a vision to outdo yesterday. This fireside chat with Drew Panayiotou, CMO of Pfizer and Devon Still, ex-NFL player and founder of Still Strong Foundation, explores innovations...
Live from SXSW - Scientific Storytelling: The Audio Advantage
April 18, 2024 09:55 - 52 minutes - 47.8 MBPodcasting has exploded in the last 5 years, with every celebrity, brand, and influencer investing in audio. It’s estimated that 144MM people in the U.S. listen to a podcast monthly. With scale and an ability to build audience connections, podcasts have become effective at communicating complex information in a digestible way–making them perfect for sharing science-based stories. Many have heard the term "gene therapy," but how many know what it means? How do you explain the science behind a...
Live from SXSW - The Future of Cancer
April 18, 2024 09:50 - 43 minutes - 40.3 MBIn a live taping of the Science Will Win podcast, Host and Artificial Intelligence Expert Jeremiah Owyang speaks to cutting-edge healthcare leaders about the impact that AI is having on the future of cancer. Thirty years ago, the thought of a world without cancer was nothing more than a dream. Similarly, AI was considered a technology that had yet to become reality. Today, we are reimagining a future where the AI revolution will help change the trajectory of cancer as we know it. Featured e...
Part 4 – Using AI to Get One Step Ahead of Antibiotic Resistance
December 05, 2023 11:00 - 31 minutes - 29 MBIs it possible to live in a world without antibiotic resistant bacteria? For the final episode of this season, we’re looking ahead to the future and getting a glimpse of a potential world in which we stay one step ahead of AMR, and what is helping us get there. Host Jeremiah Owyang and expert guests will talk about the education, surveillance, and policy efforts needed for success in the fight against antibiotic resistant bacteria. And we’ll explore how artificial intelligence can empower us...
Part 3 – AI in the Lab: Accelerating Antibiotic Discovery
November 28, 2023 11:00 - 26 minutes - 24.7 MBArtificial intelligence has the power to transform the way researchers study bacteria and develop new treatments – and we’re already seeing the benefits in healthcare. In part three, host Jeremiah Owyang and expert guests shed light on how AI expedites and enhances analyses, revolutionizing the search for new antibiotics. The benefits of AI extend to analyzing bacterial DNA, uncovering vulnerabilities, and potentially predicting bacterial evolution. This innovative technology aids scientists...
Part 2 – The Power of Data and Artificial Intelligence
November 21, 2023 11:00 - 30 minutes - 27.7 MBArtificial intelligence could be an essential tool in the fight against antibiotic resistant bacteria – and data is a key part of developing that tool. In part two of this four-part series, expert guests break down the mechanics behind artificial intelligence and machine learning. As host Jeremiah Owyang traces the evolution of these tools in healthcare, he highlights the crucial role of data for understanding the problem of antibiotic resistance. Featured Guests: Adrian Egli, Director, I...
Part 1 – The Battle Against Antibiotic Resistance
November 15, 2023 11:00 - 27 minutes - 25.6 MBMedicine’s struggle with antibiotic resistant bacteria is reaching a crisis point. In part one of this four-part series, host Jeremiah Owyang and expert guests delve into the world of antibiotics, exploring their history, the rise of antibiotic resistance, and the story of a patient whose life was forever changed by antibiotic-resistant bacteria. They break down the critical issues at stake and discuss the multifaceted solutions needed to combat this pressing crisis – including artificial in...
Coming Soon – Science Will Win, Season 3
November 07, 2023 11:00 - 4 minutes - 3.79 MBSince antibiotics were first discovered, bacteria have been evolving to outsmart them. But today, the latest science is rising up to meet the challenge. This season of Science Will Win is exploring how artificial intelligence (AI) can help the scientific community overcome one of the greatest challenges facing humanity: antimicrobial resistance. This season, we’ll hear from researchers, doctors, patients, patient advocates, computer scientists, and AI experts. All of them are on the cutting ...
Part 2: Clinical Trials: Bringing Research to Life
October 27, 2022 10:00 - 29 minutes - 27 MBIn part two of this series, Adam Rutherford and guests break down the next step in how potential breast cancer treatments move forward from the lab. What role do clinical trials play in the development of potential treatments? How are clinical trials developed? How can patients access clinical trials? And how are researchers and advocacy groups working to break down barriers in access to clinical trials? Featured Guests: Laurie, Breast Cancer Clinical Trial Participant Dr. Edith Mitchell,...
Part 1: Breast Cancer: The Science, The Challenges, The Solutions
October 27, 2022 10:00 - 30 minutes - 28.4 MBOncologists have more innovative methods for treating breast cancer than ever before. In part one of this two-part series, Adam Rutherford and guests explore the hurdles and successes researchers face as they work to develop new, targeted therapies for breast cancer. Featured Guests: Martha Carlson, Breast Cancer Advocate & Writer Dr. Edith Mitchell, Medical Oncologist, Thomas Jefferson University Jeff Settleman, Chief Scientific Officer, Pfizer Oncology
Coming Soon – Science Will Win, Season 2
October 13, 2022 10:00 - 9 minutes - 8.56 MBHost Adam Rutherford returns to explore breakthroughs in oncology, the study and treatment of cancer, and more specifically breast cancer. We’ll hear from the scientists tasked with developing new treatments, oncologists who lead clinical trials and treat patients, and the patients and patient advocates themselves. It’s a groundbreaking time for cancer research, with as many promising possibilities as there are challenges to overcome. Tune in to this new, two-part series, launching October 2...
BONUS – Into the Pfizer Lab: Making a Gene Therapy
December 10, 2021 08:00 - 14 minutes - 13.6 MBIn this special bonus episode, Adam Rutherford explores a different aspect of gene therapy - how do you actually make one? Expert guests discuss the highly complex task of scaling-up manufacturing from the small amounts needed for research, to creating batches big enough for clinical and commercial scale. And once that hurdle has been cleared, how do they address the additional challenge of storing and transporting the medicine at ultra-low temperatures? Featuring guests: Bert Bruce, Region...
What’s Next For Gene Therapy?
October 29, 2021 07:30 - 31 minutes - 28.5 MBGene therapy is at a pivotal moment. For eligible rare disease patients, the potential impact could be huge. So how can we support that potential to fruition and what will it mean if we do? In our season finale, host Adam Rutherford and guests take a peek into what a world with successful gene therapies could look like for patients, healthcare and society. Featuring guests: Durhane Wong-Rieger, President & CEO at Canadian Organization for Rare Disorders Erik Paulsen, Chair, Institute for Ge...
The Policy Puzzle
October 22, 2021 08:25 - 28 minutes - 26.6 MBAs with any new breakthrough medicine, entering the healthcare system comes with a host of obstacles and potential barriers. In this episode, Adam Rutherford and guests break down the big changes needed within the global healthcare ecosystem to ensure that, once approved, the therapies we’re researching now, like gene therapy, reach the patients who need them. Featuring guests: Bert Bruce, Regional President, North America, Rare Disease, Pfizer Brenda Cooperstone, Senior Vice President, Ch...
Clinical Trials: Courage and Perseverance
October 15, 2021 06:52 - 26 minutes - 24.4 MBGene therapy has come a long way to get where it is today but there is still much to learn and investigate. Host Adam Rutherford speaks to a line-up of experts about the vital role of clinical trials and the unique challenges facing gene therapy and rare disease patients. Featuring guests: Brenda Cooperstone, Senior Vice President, Chief Development Officer, Rare Disease, Pfizer Emily Crossley, Chief Executive Officer, Duchenne UK Erik Paulsen, Chair, Institute for Gene Therapies Professor ...
Clinical Trials; Courage and Perseverance
October 15, 2021 06:52 - 26 minutes - 24.4 MBGene therapy has come a long way to get where it is today but there is still much to learn and investigate. Host Adam Rutherford speaks to a line-up of experts about the vital role of clinical trials and the unique challenges facing gene therapy and rare disease patients. Featuring guests: Brenda Cooperstone, Senior Vice President, Chief Development Officer, Rare Disease, Pfizer Emily Crossley, Chief Executive Officer, Duchenne UK Erik Paulsen, Chair, Institute for Gene Therapies Profess...
Gene Therapy – Behind the Science
October 08, 2021 08:11 - 25 minutes - 23.4 MBGene therapy is a revolutionary field of science that has the potential to transform lives. It presents this big question; What if we could treat a disease at its root cause, rather than just the symptoms? On the first episode of Science Will Win, host Adam Rutherford takes us through the history, science, and significance of gene therapy. Featuring guests: Dirk Vander Mijnsbrugge, Vice President, Medical Affairs, Rare Diseases, Pfizer Durhane Wong-Rieger, President & CEO at Canadian Organ...
Coming soon - Science Will Win
August 31, 2021 18:57 - 8 minutes - 8.3 MBScience Will Win explores the fascinating science, policy, and humanity which is shaping the future of healthcare and transforming patients’ lives for the better. Hosted by Adam Rutherford, geneticist and Honorary Fellow at University College London, our first miniseries takes listeners on a journey behind the science of gene therapy; the next generation of medicines bringing new possibilities for patients living with rare genetic diseases. At a time when innovative science is achieving ...
New Series — Science Will Win
August 31, 2021 18:57 - 8 minutes - 8.3 MBScience Will Win explores the fascinating science, policy, and humanity which is shaping the future of healthcare and transforming patients’ lives for the better. Hosted by Adam Rutherford, geneticist and Honorary Fellow at University College London, our first miniseries takes listeners on a journey behind the science of gene therapy; the next generation of medicines bringing new possibilities for patients living with rare genetic diseases. At a time when innovative science is achieving ...